The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Body Mass Index, Metabolic Syndrome, and Risk of Type 2 Diabetes or Cardiovascular Disease
Abstract
CONTEXT: Metabolic risk conferred by adiposity may be due to associated risk factor clustering. OBJECTIVE: The objective of this study was to assess risk for diabetes or cardiovascular disease (CVD) stratified by body mass index (BMI) and the presence or absence of metabolic syndrome (MetS) or insulin resistance (IR). DESIGN, SETTING, AND PARTICIPANTS: This was a community-based, longitudinal study of 2902 people (55% women, mean age 53 yr) without diabetes or CVD in 1989-1992 followed for up to 11 yr. We categorized subjects by normal weight (BMI < 25 kg/m(2)), overweight (25-29.9 kg/m(2)), or obese (>30 kg/m(2)) and by the National Cholesterol Education Program's Adult Treatment Panel MetS or the top quartile of homeostasis model IR. We used proportional hazard models to estimate risk relative to normal weight and no MetS or IR. MAIN OUTCOME MEASURE: Incident type 2 diabetes (treatment or fasting glucose > or = 7 mmol/liter, 141 events) or CVD (myocardial infarction, stroke, or claudication, 252 events) were measured. RESULTS: Among 1056 normal-weight subjects, 7% had MetS and a risk factor-adjusted relative risk for diabetes of 3.97 (95% confidence interval, 1.35-11.6) and for CVD of 3.01 (1.68-5.41). Among 638 obese subjects, 37% did not have MetS or significantly increased risk. Obese subjects with MetS had an adjusted relative risk for diabetes of 10.3 (5.44-19.5) and for CVD of 2.13 (1.43-3.18). Results were similar in analyses of BMI-IR categories. CONCLUSIONS: People with normal weight and MetS or IR or with obesity but no MetS or IR were not uncommon in our sample. Risk factor clustering or IR appear to confer much of the risk for diabetes or CVD commonly associated with elevated BMI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
The Metabolic Syndrome: Time for a Critical Appraisal
Kahn, R., Buse, J., Ferrannini, E., & Stern, M. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2289 · Cited by 2,378
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,358
Self-citationThe Spread of the Obesity Epidemic in the United States, 1991-1998
Mokdad, A. H. (1999) · JAMA · doi:10.1001/jama.282.16.1519 · Cited by 2,280
Comment on the provisional report from the WHO consultation
(1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00059.x · Cited by 1,820 · cited 1×
“5)] and defined IR as a homeostasis model assessment (HOMA)-IR level in the top quartile of the distribution among subjects without diabetes (17, 18).”
BackgroundObesity, Fat Distribution, and Weight Gain as Risk Factors for Clinical Diabetes in Men
Chan, J. M., Rimm, E. B., Colditz, G. A., Stampfer, M. J., & Willett, W. C. (1994) · Diabetes Care · doi:10.2337/diacare.17.9.961 · Cited by 1,808
Use and misuse of population attributable fractions
Rockhill, B., Newman, B., & Weinberg, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.1.15 · Cited by 1,683
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
KANNEL, W. B., FEINLEIB, M., McNAMARA, P. M., GARRISON, R. J., & CASTELLI, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,645
Abdominal Adiposity and Coronary Heart Disease in Women
Rexrode, K. M. (1998) · JAMA · doi:10.1001/jama.280.21.1843 · Cited by 1,213
Willett, W. C., Dietz, W. H., & Colditz, G. A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410607 · Cited by 1,143
Wang, Y., Rimm, E. B., Stampfer, M. J., Willett, W. C., & Hu, F. B. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.3.555 · Cited by 1,123
Ohlson, L. O., Larsson, B., Svärdsudd, K., Welin, L., Eriksson, H., Wilhelmsen, L., Björntorp, P., & Tibblin, G. (1985) · Diabetes · doi:10.2337/diab.34.10.1055 · Cited by 1,020
Carr, D. B., Utzschneider, K. M., Hull, R. L., Kodama, K., Retzlaff, B. M., Brunzell, J. D., Shofer, J. B., Fish, B. E., Knopp, R. H., & Kahn, S. E. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2087 · Cited by 993
Ferrannini, E., Natali, A., Bell, P., Cavallo-Perin, P., Lalic, N., & Mingrone, G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119628 · Cited by 898 · cited 1×
“The latter interpretation is supported by our observation that the prevalence of BMI-metabolic risk subphenotypes and the magnitude of their associated risks for diabetes or CVD were very similar when metabolic risk was defined by the presence of IR rather than MetS (6, 7, 10, 11).”
BackgroundThe metabolically obese, normal-weight individual revisited.
Ruderman, N., Chisholm, D., Pi-Sunyer, X., & Schneider, S. (1998) · Diabetes · doi:10.2337/diabetes.47.5.699 · Cited by 893
Detection of Epstein–Barr Viral Genomes in Reed–Sternberg Cells of Hodgkin's Disease
Weiss, L. M., Movahed, L. A., Warnke, R. A., & Sklar, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902233200806 · Cited by 886
Rimm, E. B., Stampfer, M. J., Giovannucci, E., Ascherio, A., Spiegelman, D., Colditz, G. A., & Willett, W. C. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117385 · Cited by 843
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
Bonora, E., Kiechl, S., Willeit, J., Oberhollenzer, F., Egger, G., Targher, G., Alberiche, M., Bonadonna, R. C., & Muggeo, M. (1998) · Diabetes · doi:10.2337/diabetes.47.10.1643 · Cited by 837
Carey, V. J., Walters, E. E., Colditz, G. A., Solomon, C. G., Willet, W. C., Rosner, B. A., Speizer, F. E., & Manson, J. E. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009158 · Cited by 827
Zavaroni, I., Bonora, E., Pagliara, M., Dall'Aglio, E., Luchetti, L., Buonanno, G., Bonati, P. A., Bergonzani, M., Gnudi, L., Passeri, M., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903163201105 · Cited by 771
Metabolic and Body Composition Factors in Subgroups of Obesity: What Do We Know?
Karelis, A. D., St-Pierre, D. H., Conus, F., Rabasa-Lhoret, R., & Poehlman, E. T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0165 · Cited by 723
Parental transmission of type 2 diabetes: the Framingham Offspring Study
Meigs, J. B., Cupples, L. A., & Wilson, P. W. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2201 · Cited by 666
Self-citationBiomarkers of Endothelial Dysfunction and Risk of Type 2 Diabetes Mellitus
Meigs, J. B. (2004) · JAMA · doi:10.1001/jama.291.16.1978 · Cited by 643
Self-citationObesity, Regional Body Fat Distribution, and the Metabolic Syndrome in Older Men and Women
Goodpaster, B. H., Krishnaswami, S., Harris, T. B., Katsiaras, A., Kritchevsky, S. B., Simonsick, E. M., Nevitt, M., Holvoet, P., & Newman, A. B. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.7.777 · Cited by 637
Beilby, J. P. (2004) · PubMed Central · Cited by 610
Benjamin, E. J., Larson, M. G., Keyes, M. J., Mitchell, G. F., Vasan, R. S., Keaney, J. F., Lehman, B. T., Fan, S., Osypiuk, E., & Vita, J. A. (2004) · Circulation · doi:10.1161/01.cir.0000112565.60887.1e · Cited by 607
Self-citationThe metabolically healthy but obese individual presents a favorable inflammation profile
Karelis, A. D., Faraj, M., Bastard, J.-P., St-Pierre, D. H., Brochu, M., Prud’homme, D., & Rabasa-Lhoret, R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0482 · Cited by 579
Relationship between obesity, insulin resistance, and coronary heart disease risk
Abbasi, F., Brown, B. W., Lamendola, C., McLaughlin, T., & Reaven, G. M. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02051-x · Cited by 573
The “metabolically-obese,” normal-weight individual
Ruderman, N. B., Schneider, S. H., & Berchtold, P. (1981) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/34.8.1617 · Cited by 545
Hyperinsulinemia, Hyperglycemia, and Impaired Hemostasis: The Framingham Offspring Study
Meigs, J. B., Mittleman, M. A., Nathan, D. M., Tofler, G. H., Singer, D. E., Murphy-Sheehy, P. M., Lipinska, I., D'Agostino, R. B., & Wilson, P. W. F. (2000) · JAMA · doi:10.1001/jama.283.2.221 · Cited by 538
Self-citationRegional obesity and risk of cardiovascular disease; the Framingham study
Kannel, W. B., Adrienne Cupples, L., Ramaswami, R., Stokes, J., Kreger, B. E., & Higgins, M. (1991) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(91)90265-b · Cited by 535
Wei, M., Gaskill, S. P., Haffner, S. M., & Stern, M. P. (1997) · Obesity Research · doi:10.1002/j.1550-8528.1997.tb00278.x · Cited by 481
Belanger, C. F., Hennekens, C. H., Rosner, B., & Speizer, F. E. (1978) · The American Journal of Nursing · doi:10.2307/3462013 · Cited by 444
Brochu, M., Tchernof, A., Dionne, I. J., Sites, C. K., Eltabbakh, G. H., Sims, E. A. H., & Poehlman, E. T. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7365 · Cited by 443
Kip, K. E., Marroquin, O. C., Kelley, D. E., Johnson, B. D., Kelsey, S. F., Shaw, L. J., Rogers, W. J., & Reis, S. E. (2004) · Circulation · doi:10.1161/01.cir.0000115514.44135.a8 · Cited by 412
Metabolic Syndrome in Normal-Weight Americans
St-Onge, M.-P., Janssen, I., & Heymsfield, S. B. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2222 · Cited by 307
Abdominal and total adiposity and risk of coronary heart disease in men
Rexrode, K., Buring, J., & Manson, J. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801615 · Cited by 296
Can we identify metabolically healthy but obese individuals (MHO)?
Karelis, A., Brochu, M., & Rabasa-Lhoret, R. (2004) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70156-8 · Cited by 269
McLaughlin, T., Allison, G., Abbasi, F., Lamendola, C., & Reaven, G. (2004) · Metabolism · doi:10.1016/j.metabol.2003.10.032 · Cited by 268
Sinaiko, A. R., Steinberger, J., Moran, A., Prineas, R. J., Vessby, B., Basu, S., Tracy, R., & Jacobs, D. R. (2005) · Circulation · doi:10.1161/01.cir.0000161837.23846.57 · Cited by 257
Lundgren, H., Bengtsson, C., Blohmé, G., Lapidus, L., & Sjöström, L. (1989) · PubMed · Cited by 246
Dvorak, R. V., DeNino, W. F., Ades, P. A., & Poehlman, E. T. (1999) · Diabetes · doi:10.2337/diabetes.48.11.2210 · Cited by 243 · cited 2×
“In addition, the criteria defining ATP3 MetS are arbitrary; alternate schemes to define metabolic risk may be equally valid and could produce different results (5, 7, 23).”
BackgroundMurabito, J. M., Nam, B.-H., D'Agostino, R. B., Lloyd-Jones, D. M., O'Donnell, C. J., & Wilson, P. W. F. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-6-200403160-00010 · Cited by 187
Self-citationPrevalence of Uncomplicated Obesity in an Italian Obese Population
Iacobellis, G., Ribaudo, M. C., Zappaterreno, A., Iannucci, C. V., & Leonetti, F. (2005) · Obesity Research · doi:10.1038/oby.2005.130 · Cited by 168
An Investigation of Coronary Heart Disease in Families: The Framingham Offspring Study
(2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx110 · Cited by 114
Piché, M., Weisnagel, S. J., Corneau, L., Nadeau, A., Bergeron, J., & Lemieux, S. (2005) · Diabetes · doi:10.2337/diabetes.54.3.770 · Cited by 99
Thomas, G., Tomlinson, B., & Critchley, J. A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912303412715 · Cited by 99
Searching for genes underlying normal variation in human adiposity
Comuzzie, A. G., Williams, J. T., Martin, L. J., & Blangero, J. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100202 · Cited by 84
Using Metabolic Syndrome Traits for Efficient Detection of Impaired Glucose Tolerance
Meigs, J. B., Williams, K., SULLIVAN, L. M., Hunt, K. J., Haffner, S. M., Stern, M. P., Villalpando, C. G., Perhanidis, J. A., Nathan, D. M., D’Agostino, R. B., et al. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1417 · Cited by 75
Self-citationDetermination of endothelial function and early atherosclerotic changes in healthy obese women.
Oflaz, H., Özbey, N., Mantar, F., Gençhellaç, H., Mercanoğlu, F., Sencer, E., Molvalilar, S., & Orhan, Y. (2003) · PubMed · Cited by 68
Meigs, J. B. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2761 · Cited by 58
Self-citationDvořák, R., DeNino, W. F., Ades, P. A., Ades, P., & Poehlman, É. T. (1999) · Cited by 40
Kip, K. E., Marroquin, O. C., & Kelley, D. E. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.04.053 · Cited by 35
Cited by
The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
Chen, L., Magliano, D. J., & Zimmet, P. Z. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.183 · Cited by 2,227
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Blüher, M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa004 · Cited by 1,090
Kramer, C. K., Zinman, B., & Retnakaran, R. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-11-201312030-00008 · Cited by 961
Metadata
- Authors
- Meigs, J. B., Wilson, P. W. F., Fox, C. S., Vasan, R. S., Nathan, D. M., Sullivan, L. M., & D’Agostino, R. B.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-08
- Volume
- 91
- Issue
- 8
- Pages
- 2906-2912
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2119609179
- Cited by
- 1,062
- References
- 56
- FWCI
- 17.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.